Patients with contralateral breast cancer, breast cancer with distant metastasis at diagnosis, missing FGFR1 data, and those without a positive observation time were excluded (n = 391; see Supplementary Table S1), resulting in a final sample size of 503 patients. The gene discussed is FGFR1; the disease is breast carcinoma.